NVAX – Novavax, Inc.
Novavax, Inc.NVAX
$8.42Name : Novavax, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $1,368,241,536.00
EPSttm : 2.01
Novavax, Inc.
$8.42
6.13%$0.55Float Short %
33.06
Margin Of Safety %
Put/Call OI Ratio
0.44
EPS Next Q Diff
1.25
EPS Last/This Y
3.38
EPS This/Next Y
-1.87
Price
8.97
Target Price
12.89
Analyst Recom
2.44
Performance Q
26.16
Relative Volume
1.12
Beta
2.58
Ticker: NVAX
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-01-13 | NVAX | 8.69 | 0.58 | 0.06 | 306886 |
| 2026-01-14 | NVAX | 8.19 | 0.54 | 0.16 | 324311 |
| 2026-01-15 | NVAX | 7.78 | 0.53 | 0.05 | 328276 |
| 2026-01-16 | NVAX | 8.01 | 0.52 | 0.04 | 328199 |
| 2026-01-20 | NVAX | 8.2 | 0.48 | 0.04 | 194303 |
| 2026-01-21 | NVAX | 9.9 | 0.45 | 0.16 | 207240 |
| 2026-01-22 | NVAX | 9.76 | 0.47 | 0.11 | 219382 |
| 2026-01-23 | NVAX | 9.18 | 0.44 | 0.14 | 233763 |
| 2026-01-26 | NVAX | 9.63 | 0.46 | 0.22 | 220104 |
| 2026-01-27 | NVAX | 9.81 | 0.43 | 0.07 | 226778 |
| 2026-01-28 | NVAX | 9.23 | 0.42 | 0.14 | 230021 |
| 2026-01-29 | NVAX | 9.44 | 0.42 | 0.10 | 234308 |
| 2026-01-30 | NVAX | 8.85 | 0.42 | 0.21 | 236598 |
| 2026-02-02 | NVAX | 8.69 | 0.43 | 0.08 | 223166 |
| 2026-02-03 | NVAX | 8.36 | 0.42 | 0.04 | 227438 |
| 2026-02-05 | NVAX | 7.88 | 0.44 | 0.14 | 224434 |
| 2026-02-09 | NVAX | 8.69 | 0.45 | 0.17 | 217159 |
| 2026-02-10 | NVAX | 8.75 | 0.44 | 0.07 | 220018 |
| 2026-02-11 | NVAX | 9.1 | 0.44 | 0.05 | 221664 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-01-13 | NVAX | 8.68 | -5.6 | - | 2.15 |
| 2026-01-14 | NVAX | 8.19 | -5.6 | - | 2.15 |
| 2026-01-15 | NVAX | 7.77 | -5.6 | - | 2.15 |
| 2026-01-16 | NVAX | 7.99 | -5.6 | - | 2.15 |
| 2026-01-20 | NVAX | 8.19 | -5.6 | - | 2.15 |
| 2026-01-21 | NVAX | 9.90 | -5.6 | - | 2.15 |
| 2026-01-22 | NVAX | 9.76 | -5.6 | - | 2.15 |
| 2026-01-23 | NVAX | 9.18 | -5.6 | - | 2.15 |
| 2026-01-26 | NVAX | 9.63 | -5.6 | - | 2.15 |
| 2026-01-27 | NVAX | 9.81 | -5.6 | - | 2.15 |
| 2026-01-28 | NVAX | 9.24 | -5.6 | - | 2.15 |
| 2026-01-29 | NVAX | 9.44 | -5.6 | - | 2.15 |
| 2026-01-30 | NVAX | 8.85 | -5.6 | - | 2.15 |
| 2026-02-02 | NVAX | 8.69 | -5.6 | - | 2.15 |
| 2026-02-03 | NVAX | 8.36 | -5.6 | - | 2.15 |
| 2026-02-04 | NVAX | 8.28 | -5.6 | - | 2.15 |
| 2026-02-05 | NVAX | 7.88 | -5.6 | - | 2.15 |
| 2026-02-06 | NVAX | 8.24 | -5.6 | - | 2.15 |
| 2026-02-09 | NVAX | 8.69 | -6.3 | - | 2.15 |
| 2026-02-10 | NVAX | 8.76 | -6.3 | - | 2.15 |
| 2026-02-11 | NVAX | 8.97 | -6.3 | - | 2.15 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-01-13 | NVAX | 0.00 | 0.61 | 35.35 |
| 2026-01-14 | NVAX | 0.00 | 0.61 | 35.35 |
| 2026-01-15 | NVAX | 0.00 | 0.61 | 35.35 |
| 2026-01-16 | NVAX | 0.00 | 0.61 | 35.35 |
| 2026-01-20 | NVAX | 0.00 | 0.88 | 35.34 |
| 2026-01-21 | NVAX | 0.00 | 0.88 | 35.34 |
| 2026-01-22 | NVAX | 0.00 | 0.88 | 35.34 |
| 2026-01-23 | NVAX | 0.00 | 0.88 | 35.34 |
| 2026-01-26 | NVAX | 0.00 | 0.88 | 35.34 |
| 2026-01-27 | NVAX | 0.00 | 0.88 | 35.34 |
| 2026-01-28 | NVAX | 0.00 | 0.88 | 34.40 |
| 2026-01-29 | NVAX | 0.00 | 0.88 | 34.40 |
| 2026-01-30 | NVAX | 0.00 | 0.88 | 34.40 |
| 2026-02-02 | NVAX | 0.00 | 0.84 | 34.41 |
| 2026-02-03 | NVAX | 0.00 | 0.84 | 34.41 |
| 2026-02-04 | NVAX | 0.00 | 0.84 | 34.41 |
| 2026-02-05 | NVAX | 0.00 | 0.84 | 34.41 |
| 2026-02-06 | NVAX | 0.00 | 0.84 | 34.41 |
| 2026-02-09 | NVAX | 0.00 | 1.61 | 34.41 |
| 2026-02-10 | NVAX | 0.00 | 1.61 | 34.41 |
| 2026-02-11 | NVAX | 0.00 | 1.61 | 33.06 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-1.25
Avg. EPS Est. Current Quarter
-0.49
Avg. EPS Est. Next Quarter
Insider Transactions
Institutional Transactions
1.61
Beta
2.58
Average Sales Estimate Current Quarter
90
Average Sales Estimate Next Quarter
102
Fair Value
Quality Score
96
Growth Score
31
Sentiment Score
66
Actual DrawDown %
97.1
Max Drawdown 5-Year %
-98.7
Target Price
12.89
P/E
5.07
Forward P/E
58.15
PEG
1.45
P/S
1.37
P/B
P/Free Cash Flow
EPS
1.77
Average EPS Est. Cur. Y
2.15
EPS Next Y. (Est.)
0.28
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
32.1
Relative Volume
1.12
Return on Equity vs Sector %
-246
Return on Equity vs Industry %
-229.6
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
Novavax, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 952
Novavax, Inc., a biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally. The company offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.
stock quote shares NVAX – Novavax, Inc. Stock Price stock today
news today NVAX – Novavax, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch NVAX – Novavax, Inc. yahoo finance google finance
stock history NVAX – Novavax, Inc. invest stock market
stock prices NVAX premarket after hours
ticker NVAX fair value insiders trading